Bhumble
01-23-2006, 10:42 AM
CHICAGO, Jan. 19 (UPI) -- Northwestern University scientists say they have developed a novel orally administered compound to help Alzheimer's disease patients.
Gene therapy stops Parkinson's mutation (January 18, 2006) -- Northwestern University scientists say they're developing a therapy to selectively turn off a gene involved in Parkinson's disease ... > full story
Study: Cognitive decline might be slowed (January 17, 2006) -- A team of scientists at the Weizmann Institute of Science has come up with new findings that might help delay and slow cognitive deterioration in old ... > full story
Astrocytes may play role in Alzheimer's (January 6, 2006) -- Star-shaped brain cells known as astrocytes play a direct role in controlling blood flow in the brain, say New York researchers. The crucial process ... > full story
Research offers Parkinson's hope (December 29, 2005) -- Researchers say they have discovered how a gene linked to Parkinson's disease can keep brain cells alive. Scientists at the University of ... > full story
New compounds may prevent brain cell death (December 21, 2005) -- Spanish chemists say they've developed a promising set of synthetic compounds that one day may slow or halt neurological disorders. The ... > full story
The compound reportedly halts brain cell inflammation and neuron loss associated with Alzheimer's disease. The researchers note the compound is also rapidly absorbed by the brain and is non-toxic -- important considerations for a central nervous system drug that might need to be taken for extended periods.
The compound, called MW01-5-188WH, selectively inhibits production of pro-inflammatory proteins called cytokines by glia. Those are cells of the central nervous system that normally help the body mount a response, but are overactivated in certain neurodegenerative diseases -- such as Alzheimer's and Parkinson's disease, stroke and traumatic brain injury.
The compound was designed and synthesized in the laboratory of D. Martin Watterson, a professor of cell and molecular biology at Northwestern University's Feinberg School of Medicine.
The discovery is detailed in the Jan. 11 issue of the Journal of Neuroscience.
Copyright 2006 by United Press International. All Rights Reserved.
http://www.sciencedaily.com/upi/index.php?feed=Science&article=UPI-1-20060119-17572200-bc-us-alzheimers.xml
Gene therapy stops Parkinson's mutation (January 18, 2006) -- Northwestern University scientists say they're developing a therapy to selectively turn off a gene involved in Parkinson's disease ... > full story
Study: Cognitive decline might be slowed (January 17, 2006) -- A team of scientists at the Weizmann Institute of Science has come up with new findings that might help delay and slow cognitive deterioration in old ... > full story
Astrocytes may play role in Alzheimer's (January 6, 2006) -- Star-shaped brain cells known as astrocytes play a direct role in controlling blood flow in the brain, say New York researchers. The crucial process ... > full story
Research offers Parkinson's hope (December 29, 2005) -- Researchers say they have discovered how a gene linked to Parkinson's disease can keep brain cells alive. Scientists at the University of ... > full story
New compounds may prevent brain cell death (December 21, 2005) -- Spanish chemists say they've developed a promising set of synthetic compounds that one day may slow or halt neurological disorders. The ... > full story
The compound reportedly halts brain cell inflammation and neuron loss associated with Alzheimer's disease. The researchers note the compound is also rapidly absorbed by the brain and is non-toxic -- important considerations for a central nervous system drug that might need to be taken for extended periods.
The compound, called MW01-5-188WH, selectively inhibits production of pro-inflammatory proteins called cytokines by glia. Those are cells of the central nervous system that normally help the body mount a response, but are overactivated in certain neurodegenerative diseases -- such as Alzheimer's and Parkinson's disease, stroke and traumatic brain injury.
The compound was designed and synthesized in the laboratory of D. Martin Watterson, a professor of cell and molecular biology at Northwestern University's Feinberg School of Medicine.
The discovery is detailed in the Jan. 11 issue of the Journal of Neuroscience.
Copyright 2006 by United Press International. All Rights Reserved.
http://www.sciencedaily.com/upi/index.php?feed=Science&article=UPI-1-20060119-17572200-bc-us-alzheimers.xml